1,2-Diacyl-sn-glycero-3-phosphorylcholine, -ethanolamine and -serine, specifically labelled with different fatty acids at either the 1- or 2-position, were prepared enzymatically using the acyltransferase system of rat liver microsomes. The substrates were subjected to hydrolysis by phospholipase A2
On the effect of brain phospholipase A1on specifically labelled glycerophospholipids in the course of subacute sclerosing panencephalitis
✍ Scribed by Ulrike Jakumeit-Morgott; Helmut Woelk
- Publisher
- Springer
- Year
- 1975
- Tongue
- English
- Weight
- 498 KB
- Volume
- 209
- Category
- Article
- ISSN
- 0340-5354
No coin nor oath required. For personal study only.
✦ Synopsis
The effect of phospholipase A1 of human brain on 1,2-diacyl-sn-glycero-3-phosphorylcholine, -ethanolamine and -serine, specifically labelled with different fatty acids at either the 1 or 2 position, was determined in subacute sclerosing panencephalitis. An increase of approximately 40% in the specific activity of phospholipase A1 could be observed for all substrates investigated during the demyelinating disorder. On investigating the specific activity of the enzyme with various molecular species of phosphatidylcholine and -ethanolamine, labelled at the 1 position with different radioactive fatty acids, we found that the phospholipase A1 preferentially removed those fatty acids from the 1 position of phosphatidylcholines that have the fewest double bonds, while oleic and linoleic acid were released at almost similar rates from phosphatidylethanolamine.
📜 SIMILAR VOLUMES
Denys–Drash syndrome (DDS) is characterized by progressive glomerulopathy caused by diffuse mesangial sclerosis (DMS), genitourinary defects, and a higher risk of developing Wilms’ tumor. It is commonly assumed that the DMS is unresponsive to any medications. In this report, we present a patient wit
## Abstract Pregnant Wistar rats were orally treated with the adenosine receptor agonist R‐phenylisopropyladenosine (R‐PIA) throughout the gestational period, and the status of the metabotropic glutamate (mGlu) receptor/phospholipase C transduction pathway from maternal and fetal brain was analyzed